UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study

Annals of oncology, 1993-06, Vol.4 (6), p.475-479

1993

Volltextzugriff (PDF)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.122-137

2018

Volltextzugriff (PDF)

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2015-01, Vol.372 (5), p.436-446

2015

Volltextzugriff (PDF)

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2014-07, Vol.371 (2), p.107-118

2014

Volltextzugriff (PDF)

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

The lancet oncology, 2015-01, Vol.16 (1), p.67-75

2015

Volltextzugriff (PDF)

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

The lancet oncology, 2011-11, Vol.12 (12), p.1101-1108

2011

Volltextzugriff (PDF)

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.766-776

2009

Volltextzugriff (PDF)

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

The lancet oncology, 2012-04, Vol.13 (4), p.420-432

2012

Volltextzugriff (PDF)

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Breast cancer research : BCR, 2011-05, Vol.13 (3), p.209-209, Article 209

2011

Volltextzugriff (PDF)

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

Breast cancer research and treatment, 2009-01, Vol.113 (1), p.137-144

2009

Volltextzugriff (PDF)

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data

International journal of cancer, 2009-06, Vol.124 (12), p.2960-2965

2009

Volltextzugriff (PDF)

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Breast cancer research and treatment, 2012-01, Vol.131 (1), p.295-306

2012

Volltextzugriff (PDF)

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93

Breast cancer research and treatment, 2009-08, Vol.116 (3), p.491-500

2009

Volltextzugriff (PDF)

The symptomatic control of cytostatic drug-induced emesis. A recent history and review

European journal of cancer (1990), 1990, Vol.26 Suppl 1, p.S2

1990

Volltextzugriff (PDF)

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Annals of oncology, 2009-08, Vol.20 (8), p.1344-1351

2009

Volltextzugriff (PDF)

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Annals of oncology, 2008-04, Vol.19 (4), p.660-668

2008

Volltextzugriff (PDF)

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Clinical trials (London, England), 2009-06, Vol.6 (3), p.272-287

2009

Volltextzugriff (PDF)

Effect of cold environment on skeletal muscle mitochondria in growing rats

Cell and tissue research, 1982-07, Vol.225 (2), p.427-436

1982

Volltextzugriff (PDF)

The symptomatic control of cytostatic drug-induced emesis. A recent history and review

European journal of cancer & clinical oncology, 1990, Vol.26, p.S2-S8

1990

Volltextzugriff (PDF)

Outcome reliability in non-Ambulatory Boys/Men with duchenne muscular dystrophy

Muscle & nerve, 2015-04, Vol.51 (4), p.522-532

2015

Volltextzugriff (PDF)

One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development

Pediatric neurology, 2014-06, Vol.50 (6), p.557-563

2014

Volltextzugriff (PDF)

A rapid, instrument-free, sample-to-result nucleic acid amplification test

Lab on a chip, 2016-01, Vol.16 (19), p.3777-3787

2016

Volltextzugriff (PDF)

Scoping review of qualitative studies investigating reproductive health knowledge, attitudes, and practices among men and women across Rwanda

PloS one, 2023-03, Vol.18 (3), p.e0283833-e0283833

2023

Volltextzugriff (PDF)

Enhanced Bone Apposition to a Chemically Modified SLA Titanium Surface

Journal of dental research, 2004-07, Vol.83 (7), p.529-533

2004

Volltextzugriff (PDF)

1 – 25 von 467

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406)
Mit Volltextzugriff
(371)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93

The symptomatic control of cytostatic drug-induced emesis. A recent history and review

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Effect of cold environment on skeletal muscle mitochondria in growing rats

The symptomatic control of cytostatic drug-induced emesis. A recent history and review

Outcome reliability in non-Ambulatory Boys/Men with duchenne muscular dystrophy

One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development

A rapid, instrument-free, sample-to-result nucleic acid amplification test

Scoping review of qualitative studies investigating reproductive health knowledge, attitudes, and practices among men and women across Rwanda

Enhanced Bone Apposition to a Chemically Modified SLA Titanium Surface

Suchergebnisse filtern